Samyang’s Surgical Suture is produced and sold in accordance with the international quality system, ISO 13485, and Surgisorb®, which is a finished product, acquired the U.S. FDA certification in 1999 and CE marking, the European quality certification, in 2002.
In 2019, we developed and launched Monofix®, which is a barbed suture used commonly for laparoscopy and robot surgery as it does not need knots, and in 2022 launched Neosorb® Plus, an antibacterial suture that reduces the risk of infection after a surgery, for the first time in Korea.
This product group comprises sterile
absorbable sutures used for the human body.
This product group consists of medical devices for wound closure ideal
for minimally invasive surgeries (MIS).